Intravitreal Methotrexate for the Prevention and Treatment of Proliferative Vitreoretinopathy in Rhe...
Intravitreal Methotrexate for the Prevention and Treatment of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment: A Systematic Review
About this item
Full title
Author / Creator
Publisher
United States: Slack, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Slack, Inc
Subjects
More information
Scope and Contents
Contents
This systematic review evaluates the role of methotrexate (MTX) as an adjunctive intravitreal agent for the prevention and treatment of proliferative vitreoretinopathy (PVR) in rhegmatogenous retinal detachment. Articles investigating the use of MTX in ≥5 patients with PVR or high risk of PVR were identified via searches of OVID MED-LINE, EMBASE, a...
Alternative Titles
Full title
Intravitreal Methotrexate for the Prevention and Treatment of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment: A Systematic Review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2724635405
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2724635405
Other Identifiers
ISSN
2325-8160
E-ISSN
2325-8179
DOI
10.3928/23258160-20220920-04
